Results 71 to 80 of about 45,638 (231)
ABSTRACT Amniotic fluid embolism (AFE) is a devastating and unpredictable obstetric emergency typically characterized by sudden cardiopulmonary collapse and coagulopathy during or shortly after delivery. It is triggered by an anaphylactoid‐histamine‐mediated systemic response, evidently with no available confirmatory tests in living patients.
Aniceth Muchunguzi +4 more
wiley +1 more source
The Inferior Epigastric Artery: An Alternative Arterial Conduit for Coronary Artery Bypass Surgery [PDF]
Fitxes dels ...
Michel Buche +13 more
core +1 more source
Gold nanoparticles are revolutionizing medicine with their unique properties including optical, electrical, physical, and chemical features, as well as surface plasmon resonance. This versatility has positioned GNPs as a cornerstone in nanotechnology, especially within biomedical applications. Their facile synthesis and surface functionalization enable
Nastaran Mohseni +4 more
wiley +1 more source
Coronary subclavian steal syndrome with retrograde blood flow in the left internal mammary-coronary bypass graft is a rare but severe complication of cardiac surgery.
Jiri Mandak +3 more
doaj +1 more source
Cadaveric addendum to the consensus on ultrasound‐based lymph‐node staging in gynecological cancer
Ultrasound in Obstetrics &Gynecology, EarlyView.
D. Fischerova +13 more
wiley +1 more source
Segments of the canine internal mammary artery (35 mm in length) were suspended in vitro in an organ chamber containing physiological salt solution (95% O2/5% CO2, pH = 7.4, 37°C). Segments were individually cannulated and perfused at 5 ml/minute using a
Rodrigues Alfredo J +5 more
doaj +1 more source
216 Jewish Hospital of St. Louis [PDF]
https://digitalcommons.wustl.edu/bjc_216/1187/thumbnail ...
core +1 more source
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks +5 more
wiley +1 more source
Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck +4 more
wiley +1 more source
Tuberculosis is still an endemic in many parts of the world. Vascular complications have been described in patients with tuberculosis and in aggressive chest infections such as actinomycoses.
Payal Mittal +3 more
doaj +1 more source

